von willebrand factor
UkraineDrugs containing this active substance
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital or acquired factor VIII deficiency) and in von Willebrand disease, if treatment with desmopressin alone is ineffective or contraindicated.
Form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 250 IU von willebrand factor 190 IU ATC: B02BD06
-
The drug is used for the therapy and prevention of bleeding in patients with hemophilia A (congenital or acquired factor VIII deficiency), as well as in von Willebrand disease, if treatment with desmopressin is ineffective or contraindicated.
Form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 500 IU von willebrand factor 375 IU ATC: B02BD06
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (due to factor VIII deficiency) and von Willebrand disease (if factor VIII deficiency is present).
Form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 1000 IU von willebrand factor 750 IU ATC: B02BD06
-
The drug is used for the prevention and treatment of bleeding in von Willebrand disease (when other methods are ineffective or contraindicated), as well as for the treatment and prevention of bleeding in patients with hemophilia A.
Form: powder and solvent for injection solution
Active substance Dosage factor viii human coagulation 1000 IU von willebrand factor 1000 IU ATC: B02BD06
-
The drug is used for the prevention and treatment of bleeding in von Willebrand disease (when other methods are ineffective) and in hemophilia A (congenital factor VIII deficiency).
Form: powder and solvent for injection solution
Active substance Dosage factor viii human coagulation 500 IU von willebrand factor 500 IU ATC: B02BD06